Absorption, distribution, and elimination of tea polyphenols in rats

Drug Metabolism and Disposition

Volumn 25, Issue 9, 1997, Pages 1045-1050

  Chen, Laishun ^b   Lee, Mao Jung ^b   Li, He ^b   Yang, Chung S ^a  

^a RUTGERS UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EPICATECHIN; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE;

ANIMAL EXPERIMENT; ARTICLE; BILIARY EXCRETION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG METABOLISM; DRUG TISSUE LEVEL; INTRAGASTRIC DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; URINARY EXCRETION;

ADMINISTRATION, ORAL; ANIMALS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CATECHIN; FLAVONOIDS; HALF-LIFE; INJECTIONS, INTRAVENOUS; KIDNEY; LIVER; LUNG; MALE; METABOLIC CLEARANCE RATE; RATS; RATS, SPRAGUE-DAWLEY; TEA;

ANIMALIA;

EID: 0030763576     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. C. S. Yang and Z.-Y. Wang: Tea and cancer. J. Natl. Cancer Inst. 85, 1038-1049 (1993).
2. C. S. Yang, L. Chen, M.-J. Lee, and J. M. Landau: Effects of tea on carcinogenesis in animal models and humans. In "Dietary Phytochemicals in Cancer Prevention and Treatment" (R. R. Butrum, ed.), pp. 51-61. Plenum Press, New York, 1996.
3. W. Zheng, T. J. Doyle, L. H. Kushi, T. A. Sellers, C. P. Hong, and A. R. Folsom: Tea consumption and cancer incidence in a prospective cohort study of postmenopausal women. Am. J. Epidemiol. 144, 175-182 (1966).
4. Y. T. Gao, J. K. McLaughlin, W. J. Blot, B. T. Ji, Q. Dai, and J. J. Fraumeni: Reduced risk of esophageal cancer associated with green tea consumption. J. Natl. Cancer Inst. 86, 855-858 (1994).
5. A. Shibata, T. M. Mack, H. A. Paganini, R. K. Ross, and B. E. Henderson: A prospective study of pancreatic cancer in the elderly. Int. J. Cancer 58, 46-49 (1994).
6. L. E. Hansson, O. Nyren, R. Bergstrom, A. Wolk, A. Lindgren, J. Baron, and H. O. Adami: Diet and risk of gastric cancer. A population-based case-control study in Sweden. Int. J. Cancer 55, 181-189 (1993).
7. F. Memik, S. O. Nak, M. Gulten, and M. Ozturk: Gastric carcinoma in northwestern Turkey: epidemiologic characteristics. J. Environ. Pathol. Toxicol. Oncol. 11, 335-338 (1992).
8. R. A. Goldbohm, M. G. L. Hertog, H. A. M. Brants, G. van Poppel, and P. A. van der Brandt: Consumption of black tea and cancer risk: a prospective cohort study. J. Natl. Cancer Inst. 88, 93-100 (1996).
9. M. A. Bokuchava and N. I. Skobeleva: The biochemistry and technology of tea manufacture. Crit. Rev. Food Sci. Nutr. 12, 303-370 (1980).
10. H. Graham: Green tea composition, consumption, and polyphenol chemistry. Prev. Med. 21, 334-350 (1992).
11. M.-J. Lee, Z.-Y. Wang, L. He, L. Chen, S. Yang. S. Gobbo, D. A. Balentine, and C. S. Yang: Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epi. Biomar. Prev. 4, 393-399 (1995).
12. K. Yamaoke, T. Nakagawa, and T. Uno: Application of Akaike's Information Criterion (AIC) in the evaluation of linear pharmacokinetic equations. J. Pharmacokinet. Biopharm. 6, 165-175 (1978).
13. G. Schwartz: Estimating the dimension of a model. Ann. Stat. 6, 461 (1978).
14. M. Gibaldi and D. Perrier: Pharmacokinetics, vol. 15, Marcel Dekker. New York, 1982.
15. A. E. Hagerman: Chemistry of tannin-protein complexation. In "Chemistry and Significance of Condensed Tannins" (R. W. Hemingway and J. J. Karchesy, eds.), pp. 323-333. Plenum Press, New York, 1989.
16. G. Levy and W. K. Cheung: Pharmacological consequences of warfarinprotein binding. In "Protein Binding and Drug Transport" (J.-P. Tillement and E. Lindenlaub, eds.), pp. 445-457. F. K. Schattauer Verlag, Stuttgart, 1985.